Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial

The addition of inhaled budesonide to usual care is safe and may reduce the risk of disease progression in patients hospitalised because of COVID-19 pneumonia https://bit.ly/3tEQo3p

Detalles Bibliográficos
Autores principales: Agustí, Alvar, De Stefano, Gaston, Levi, Alberto, Muñoz, Xavier, Romero-Mesones, Christian, Sibila, Oriol, Lopez-Giraldo, Alejandra, Plaza Moral, Vicente, Curto, Elena, Echazarreta, Andrés L., Márquez, Silvana E., Pascual-Guàrdia, Sergi, Santos, Salud, Marin, Alicia, Valdés, Luis, Saldarini, Fernando, Salgado, Clara, Casanovas, Georgina, Varea, Sara, Ríos, José, Faner, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832375/
https://www.ncbi.nlm.nih.gov/pubmed/35144989
http://dx.doi.org/10.1183/13993003.03036-2021
Descripción
Sumario:The addition of inhaled budesonide to usual care is safe and may reduce the risk of disease progression in patients hospitalised because of COVID-19 pneumonia https://bit.ly/3tEQo3p

Ejemplares similares